| Issue Date | Title | Author(s) |
| 15-Apr-2013 | Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E | Supachai Rerks-Ngarm; Robert M. Paris; Supamit Chunsutthiwat; Nakorn Premsri; Chawetsan Namwat; Chureeratana Bowonwatanuwong; Shuying S. Li; Jaranit Kaewkungkal; Rapee Trichavaroj; Nampueng Churikanont; Mark S. De Souza; Charla Andrews; Donald Francis; Elizabeth Adams; Jorge Flores; Sanjay Gurunathan; Jim Tartaglia; Robert J. O'Connell; Chirapa Eamsila; Sorachai Nitayaphan; Viseth Ngauy; Prasert Thongcharoen; Prayura Kunasol; Nelson L. Michael; Merlin L. Robb; Peter B. Gilbert; Jerome H. Kim; Thailand Ministry of Public Health; US Military HIV Research Program; Chonburi Regional Hospital; Fred Hutchinson Cancer Research Center; Mahidol University; Armed Forces Research Institute of Medical Sciences, Thailand; Global Solutions in Infectious Diseases; National Institute of Allergy and Infectious Diseases; Sanofi Pasteur; Royal Thai Army |
| 20-Jan-2012 | HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX ® B/E | Robert Paris; Sasitorn Bejrachandra; Prasert Thongcharoen; Sorachai Nitayaphan; Punnee Pitisuttithum; Anna Sambor; Sanjay Gurunathan; Donald Francis; Silvia Ratto-Kim; Chitraporn Karnasuta; Mark S. de Souza; Victoria R. Polonis; Arthur E. Brown; Jerome H. Kim; Henry A. Stephens; Armed Forces Research Institute of Medical Sciences, Thailand; Faculty of Medicine, Siriraj Hospital, Mahidol University; Mahidol University; United States Military HIV Research Program/Henry M. Jackson Foundation; Sanofi Pasteur; Global Solutions for Infectious Diseases; Walter Reed Army Institute of Research; UCL |
| 1-Jan-2015 | Machine learning methods enable predictive modeling of antibody feature:function relationships in RV144 vaccinees | Ickwon Choi; Amy W. Chung; Todd J. Suscovich; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Robert J. O'Connell; Donald Francis; Merlin L. Robb; Nelson L. Michael; Jerome H. Kim; Galit Alter; Margaret E. Ackerman; Chris Bailey-Kellogg; Dartmouth College; Massachusetts General Hospital; Thailand Ministry of Public Health; Mahidol University; Armed Forces Research Institute of Medical Sciences, Thailand; Global Solutions for Infectious Diseases; Walter Reed Army Institute of Research; Henry Jackson Foundation; Thayer School of Engineering at Dartmouth |
| 1-Aug-2012 | Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials | David C. Montefiori; Chitraporn Karnasuta; Ying Huang; Hasan Ahmed; Peter Gilbert; Mark S. De Souza; Robert McLinden; Sodsai Tovanabutra; Agnes Laurence-Chenine; Eric Sanders-Buell; M. Anthony Moody; Mattia Bonsignori; Christina Ochsenbauer; John Kappes; Haili Tang; Kelli Greene; Hongmei Gao; Celia C. Labranche; Charla Andrews; Victoria R. Polonis; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Steve G. Self; Phillip W. Berman; Donald Francis; Faruk Sinangil; Carter Lee; Jim Tartaglia; Merlin L. Robb; Barton F. Haynes; Nelson L. Michael; Jerome H. Kim; Duke University School of Medicine; Armed Forces Research Institute of Medical Sciences, San Francisco; Fred Hutchinson Cancer Research Center; Walter Reed Army Institute of Research; University of Alabama; Ministry of Public Health; Mahidol University; University of California, Santa Cruz; Global Solutions for Infectious Diseases; Sanofi Pasteur |
| 26-Sep-2013 | Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial | Raphael Gottardo; Robert T. Bailer; Bette T. Korber; S. Gnanakaran; Joshua Phillips; Xiaoying Shen; Georgia D. Tomaras; Ellen Turk; Gregory Imholte; Larry Eckler; Holger Wenschuh; Johannes Zerweck; Kelli Greene; Hongmei Gao; Phillip W. Berman; Donald Francis; Faruk Sinangil; Carter Lee; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Punnee Pitisuttithum; James Tartaglia; Merlin L. Robb; Nelson L. Michael; Jerome H. Kim; Susan Zolla-Pazner; Barton F. Haynes; John R. Mascola; Steve Self; Peter Gilbert; David C. Montefiori; Fred Hutchinson Cancer Research Center; National Institute of Allergy and Infectious Diseases; Los Alamos National Laboratory; Duke University School of Medicine; JPT Peptide Technologies GmbH; University of California, Santa Cruz; Global Solutions for Infectious Diseases; Armed Forces Research Institute of Medical Sciences, Thailand; Thailand Ministry of Public Health; Mahidol University; Department of Research and Development; Walter Reed Army Institute of Research; VA Medical Center; NYU School of Medicine |
| 19-Mar-2014 | Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines | Amy W. Chung; Musie Ghebremichael; Hannah Robinson; Eric Brown; Ickwon Choi; Sophie Lane; Anne Sophie Dugast; Matthew K. Schoen; Morgane Rolland; Todd J. Suscovich; Alison E. Mahan; Larry Liao; Hendrik Streeck; Charla Andrews; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Mark S. De Souza; Jaranit Kaewkungwal; Punnee Pitisuttithum; Donald Francis; Nelson L. Michael; Jerome H. Kim; Chris Bailey-Kellogg; Margaret E. Ackerman; Galit Alter; Massachusetts Institute of Technology; Thayer School of Engineering at Dartmouth; Dartmouth College; Walter Reed Army Institute of Research; Duke University; Thailand Ministry of Public Health; Armed Forces Research Institute of Medical Sciences, Thailand; Mahidol University; Global Solutions for Infectious Diseases |
| 1-Jul-2012 | Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: A post-hoc analysis of the Thai phase 3 efficacy trial RV 144 | Merlin L. Robb; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Punnee Pitisuttithum; Jaranit Kaewkungwal; Prayura Kunasol; Chirasak Khamboonruang; Prasert Thongcharoen; Patricia Morgan; Michael Benenson; Robert M. Paris; Joseph Chiu; Elizabeth Adams; Donald Francis; Sanjay Gurunathan; Jim Tartaglia; Peter Gilbert; Don Stablein; Nelson L. Michael; Jerome H. Kim; Walter Reed Army Institute of Research; Thailand Ministry of Public Health; Armed Forces Research Institute of Medical Sciences, Thailand; Mahidol University; Biophics; Henry Jackson Foundation; Walter Reed National Military Medical Center; National Institute of Allergy and Infectious Diseases; Global Solutions for Infectious Diseases; Sanofi Pasteur; Fred Hutchinson Cancer Research Center; The EMMES Corporation; US Army Medical Materiel Development Activity |
| 1-Nov-2007 | Social harms in injecting drug users participating in the first phase III HIV vaccine trial in Thailand | Punnee Pitisuttithum; Kachit Choopanya; Valai Bussaratid; Suphak Vanichseni; Frits Van Griensven; Benjaluck Phonrat; Michael Martin; Eiam Vimutsunthorn; Udomsak Sangkum; Dwip Kitayaporn; Jordan W. Tappero; William Heyward; Donald Francis; Mahidol University; Bangkok Vaccine Evaluation Group; Thailand Ministry of Public Health; Bangkok Metropolitan Administration; Global Solutions |
| 19-Mar-2014 | Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination | Nicole L. Yates; Hua Xin Liao; Youyi Fong; Allan DeCamp; Nathan A. Vandergrift; William T. Williams; S. Munir Alam; Guido Ferrari; Zhi Yong Yang; Kelly E. Seaton; Phillip W. Berman; Michael D. Alpert; David T. Evans; Robert J. O'Connell; Donald Francis; Faruk Sinangil; Carter Lee; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Punnee Pitisuttithum; James Tartaglia; Abraham Pinter; Susan Zolla-Pazner; Peter B. Gilbert; Gary J. Nabel; Nelson L. Michael; Jerome H. Kim; David C. Montefiori; Barton F. Haynes; Georgia D. Tomaras; Duke University; Fred Hutchinson Cancer Research Center; National Institute of Allergy and Infectious Diseases; University of California, Santa Cruz; Harvard Medical School; Armed Forces Research Institute of Medical Sciences, Thailand; Global Solutions for Infectious Diseases; Thailand Ministry of Public Health; Mahidol University; Sanofi Pasteur; Rutgers New Jersey Medical School; NYU School of Medicine; Walter Reed Army Institute of Research; Sanofi; University of Wisconsin Madison |
